Eczema

New data showed delgocitinib cream maintained symptom relief and treatment success in adults with chronic hand eczema, LEO Pharma announced in a press release.

In this edition, FDA issues complete response letter for relabotulinumtoxinA; mucocutaneous manifestations may signal COVID-induced inflammatory disease in children and more.

Cashew allergy impacted 1.49% of infants and cashew sensitization impacted 1.96% of infants, both at age 12 months, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Eczema, a chronic skin disease, affects about 31.6 million Americans with potentially debilitating physical pain and discomfort, as well as putting a significant damper on their social and emotional well-being.

With dozens of topical therapies and systemic treatments available for atopic dermatitis, clinicians have many options. But a pair of reviews in The Journal of Allergy and Clinical Immunology may help them narrow down their choices.

NEW YORK — Speakers at the Skin of Color Update 2023 meeting discussed the additional diagnostic criteria that are necessary to consider in order to properly diagnose eczema in patients with skin of color.

Changes in the gut microbiota of infants preceded the development of eczema, according to a study published in mSystems.

PARK CITY, Utah — Physicians should mind variations in atopic dermatitis presentation among patients of different races, according to a presentation here.

The European Medicines Agency has validated the marketing authorization application for delgocitinib cream for moderate to severe chronic hand eczema treatment, LEO Pharma announced in a press release.

Zerigo Health has appointed Lisa Rometty as its new CEO, according to a company release.